EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma

Chehyun Nam iD, Li-Yan Li, Qian Yang, Benjamin Ziman, Hua Zhao iD, Boyan Hu, Casey Collet, Pei Jing, Qifang Lei, Li-Yan Xu iD, En-Min Li iD, H Phillip Koeffler und 2 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2320835121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Chehyun Nam und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, …. Hauptthemen laut MEDLINE: Methionine, Large Neutral Amino Acid-Transporter 1, Gene Expression Regulation, Neoplastic, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, Wright Foundation Transformative Cancer Grant Program, NIH/NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Upper aerodigestive squamous cell carcinoma (UASCC) is a common and aggressive malignancy with few effective therapeutic options. Here, we investigate amino acid metabolism in this cancer, surprisingly noting that UASCC exhibits the highest methionine level across all human cancers, driven by its transporter LAT1. We show that LAT1 is also expressed at the highest level in UASCC, transcriptionally activated by UASCC-specific promoter and enhancers, which are directly coregulated by SCC master regulators TP63/KLF5/SREBF1. Unexpectedly, unbiased bioinformatic screen identifies EZH2 as the most significant target downstream of the LAT1-methionine pathway, directly linking methionine metabolism to epigenomic reprogramming. Importantly, this cascade is indispensable for the survival and proliferation of UASCC patient-derived tumor organoids. In addition, LAT1 expression is closely associated with cellular sensitivity to inhibition of the LAT1-methionine-EZH2 axis. Notably, this unique LAT1-methionine-EZH2 cascade can be targeted effectively by either pharmacological approaches or dietary intervention in vivo. In summary, this work maps a unique mechanistic cross talk between epigenomic reprogramming with methionine metabolism, establishes its biological significance in the biology of UASCC, and identifies a unique tumor-specific vulnerability which can be exploited both pharmacologically and dietarily.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethionineLarge Neutral Amino Acid-Transporter 1Gene Expression Regulation, NeoplasticCarcinoma, Squamous CellHumansEnhancer of Zeste Homolog 2 ProteinCell Line, TumorEpigenesis, GeneticEpigenomicsHead and Neck NeoplasmsMiceSquamous Cell Carcinoma of Head and NeckAnimalsCell ProliferationKruppel-Like Transcription FactorsCellular Reprogramming

Stichwörter der Autor:innen

LAT1UASCCcancer metabolismepigenomicsmethionine

Substanzen

MethionineLarge Neutral Amino Acid-Transporter 1Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanSLC7A5 protein, humanKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033.
  • The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
  • Department of Urology, South China Hospital of Shenzhen University, Shenzhen, Guangdong 518116, China.
  • Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.

ORCID-Profile: Chehyun Nam, Hua Zhao, Li-Yan Xu, En-Min Li

Förderung

  • NIDCR NIH HHS
  • Wright Foundation Transformative Cancer Grant Program
  • NIH/NCI
  • Li Ka Shing Foundation (LKSF)
  • Watt Family Endowed Chair for Head and Neck Cancer Research
  • NCI NIH HHS
  • Ming Hsieh Institute for Research of Engineering-Medicine for Cancer

Zitieren

APA

Nam, C., Li, L. Y., Yang, Q., Ziman, B., Zhao, H., Hu, B., Collet, C., Jing, P., Lei, Q., Xu, L. Y., Li, E. M., Koeffler, H. P., Sinha, U. K., & Lin, D. C. (2024). A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2320835121

Vancouver

Nam C, Li LY, Yang Q, Ziman B, Zhao H, Hu B, et al. A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2320835121

BibTeX
@article{Nam2024,
  author = {Nam, Chehyun and Li, Li-Yan and Yang, Qian and Ziman, Benjamin and Zhao, Hua and Hu, Boyan and Collet, Casey and Jing, Pei and Lei, Qifang and Xu, Li-Yan and Li, En-Min and Koeffler, H Phillip and Sinha, Uttam K and Lin, De-Chen},
  title = {A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2320835121}
}
Kostenlos starten →